Dr. Gainor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114Phone+1 617-726-2862
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014- Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
- Harvard Medical SchoolClass of 2008
Certifications & Licensure
MA State Medical License 2010 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) Start of enrollment: 2020 Apr 23
- Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer Start of enrollment: 2015 Oct 01
Roles: Principal Investigator, Contact
- Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination Start of enrollment: 2015 Dec 01
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Evolution of first versus next-line targeted therapies for metastatic non-small cell lung cancer.Sarah Waliany, Jessica J Lin, Justin F Gainor
Trends in Cancer. 2025-01-30 - Association of Sarcopenia With Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset Validation.Anurag Saraf, John He, Kee-Young Shin, Jakob Weiss, Mark M Awad
Clinical Lung Cancer. 2025-01-28 - 1 citationsHypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer.Camila Robles-Oteíza, Katherine Hastings, Jungmin Choi, Isabelle Sirois, Arvind Ravi
The Journal of Experimental Medicine. 2025-01-06
Press Mentions
Individualized Cancer Therapy Demonstrates Safety and Sustained Immune ResponsesAugust 8th, 2024- HER2 and Lung CancerJune 7th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
